ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 164 filers reported holding ANIKA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $217,000 | -58.8% | 5,100 | -60.5% | 0.00% | -50.0% |
| Q1 2021 | $527,000 | +22.3% | 12,922 | +35.7% | 0.00% | 0.0% |
| Q4 2020 | $431,000 | -64.0% | 9,525 | -71.8% | 0.00% | -71.4% |
| Q3 2020 | $1,197,000 | -52.7% | 33,821 | -49.6% | 0.01% | -56.2% |
| Q2 2020 | $2,533,000 | +122.0% | 67,154 | +70.2% | 0.02% | +77.8% |
| Q1 2020 | $1,141,000 | +2.1% | 39,463 | +83.2% | 0.01% | +28.6% |
| Q4 2019 | $1,117,000 | +56.4% | 21,542 | +65.7% | 0.01% | +16.7% |
| Q3 2019 | $714,000 | +44.2% | 13,000 | +6.8% | 0.01% | +50.0% |
| Q2 2019 | $495,000 | -39.2% | 12,173 | -54.7% | 0.00% | -42.9% |
| Q1 2019 | $814,000 | +278.6% | 26,900 | +425.5% | 0.01% | +600.0% |
| Q3 2018 | $215,000 | -72.5% | 5,119 | -79.0% | 0.00% | -75.0% |
| Q2 2018 | $782,000 | +928.9% | 24,408 | +1120.4% | 0.00% | +300.0% |
| Q4 2015 | $76,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
| CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
| Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
| DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
| Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
| Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
| Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
| Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |